Examination of Dysglycaemia among Newly Diagnosed Tuberculosis Patients in Ghana: A Cross-Sectional Study

Table 5

Evaluating the effect of clinical and lifestyle factors on 2HPP.

	2HPP			2HPP
	Unadjusted effect of clinical and lifestyle factors on 2HPP: model 11			Effect of clinical and lifestyle factors on 2HPP controlling for Sociodemographic factors: model 12
	OR	95 CI	p-value	aOR	95 CI	p-value
BMI	0.82	0.68 - 0.97	0.024	0.86	0.7 - 1.05	0.141
Waist circumference	1.05	0.98 - 1.14	0.168	1.02	0.94 - 1.12	0.627
Hip circumference	1.00	0.92 - 1.09	0.949	1.00	0.91 - 1.09	0.937
Systolic BP	1.01	0.98 - 1.04	0.497	1.00	0.97 - 1.03	0.819
Diastolic BP	1.00	0.95 - 1.05	0.997	1.01	0.96 - 1.06	0.783
Smoking
No	ref
Yes	0.52	0.1 - 2.68	0.433	0.35	0.05 - 2.36	0.284
Alcohol intake
No	ref
Yes	0.90	0.29 - 2.83	0.862	0.69	0.18 - 2.58	0.579
AUROC (95 CI)	63.16% (53.88 - 72.43)			73.39% (65.29 - 81.48)
AIC		204.7			216.85
HL GOF	= 4.96	p=0.762		= 7.01	p=0.536

OR: odds ratio, aOR: adjusted odds ratio, CI: confidence interval, Ref: reference category, p<0.05, p<0.01, p<0.001, AUROC: Area under receiver operating characteristic curve, AIC: Akaike Information Criterion, HL GOF: Hosmer Lemeshow Goodness of fit test.